IQVIA™ Real-World Insights Bibliography
A cross-sectional survey to evaluate prescribers' knowledge and understanding of safety messages following Dengvaxia® product information update
|
Author(s): Mariana F Almas 1, Massoud Toussi 2, Elisa Valero 3, Annick Moureau 4, Lydie Marcelon |
Affiliations(s): 1IQVIA Real World Solutions, Porto Salvo, Portugal.
2IQVIA Real World &Analytics Solutions, La Défense, France.
3Global Pharmacovigilance, Sanofi Pasteur, Lyon, France.
4Global Biostatistical Sciences, Sanofi Pasteur, Marcy l'Etoile, France.
5Epidemiology and Benefit Risk, Global Pharmacovigilance, Sanofi Pasteur, Lyon, France. |
Publication(s): Pharmacoepidemiol Drug Saf
. 2022 Jul;31(7):758-768. doi: 10.1002/pds.5447. Epub 2022 May 13
|
Document Type(s): Article, |
Countries: Brazil, Thailand, |
Click here for the abstract |
C: Y: |
Immunology and Vaccination, Risk Management & REMS, 2022 |
|
L: A: |
English Clinical setting: Primary care, Epidemiological study, Survey research, |
|
|
|
|
Risk Factors and Medical Resource Utilization of Respiratory Syncytial Virus, Human Metapneumovirus and Influenza Related Hospitalizations in Adults ? A Global Study During the 2017-2019 Epidemic Seasons (Hospitalized Acute Respiratory Tract Infection [HARTI] Study) |
Author(s): Ann R Falsey, Edward E Walsh, Stacey House, Yannick Vandenijck, Xiaohui Ren, Sofia Keim, Diye Kang, Pascale Peeters, James Witek, Gabriela Ispas |
Affiliations(s): University Of Rochester School Of Medicine and Rochester Regional Health, Rochester, NY, United States; Washington University School of Medicine, St Louis, MO, United States; Janssen Infectious Diseases, Beerse, Belgium; IQVIA Real-World Solutions, Courbevoie, France; Janssen Research & Development, LLC, Titusville, NJ, United States |
Publication(s): |
Document Type(s): Article, |
Countries: Argentina, Australia, Brazil, Canada, France, Germany, Japan, Korea, Malaysia, Mexico, South Africa, USA, |
Click here for the abstract |
C: Y: |
Infectious disease, 2021 |
|
L: A: |
English Burden of illness, Clinical setting: hospital, Epidemiological study, Observational study, Patient questionnaire, Prospective study, |
|
|
|
|
Office-based Approach to Urinary Tract Infections in 50 000 Patients: Results From the REWIND Study
|
Author(s): Cai T, Palagin I, Brunelli R, Cipelli R, Pellini E, Truzzi JC, Van Bruwaene S
|
Affiliations(s): Cai T: Department of Urology, Santa Chiara Regional Hospital, Trento, Italy. Cipelli: Obs Studies Consultat, IQVIA, RWS, Milan, Italy.
|
Publication(s): |
Document Type(s): Article, |
Countries: Belgium, Brazil, Italy, Russian Federation, |
Click here for the abstract |
C: Y: |
Miscellaneous, 2021 |
|
L: A: |
English clinical setting: Secondary care, Epidemiological study, Retrospective database analysis, |
|
|
|
|
Annualized Hospitalization Rate With Natalizumab vs Fingolimod in Second-Line Treatment for RRMS in the Public Healthcare System in Brazil: A Claim Database Approach |
Author(s): Guilherme Silva Julian 1,
Ricardo Papaléo Rosim 2,
Estela Cristina Carneseca 3,
Jéssica Rigolon 2 |
Affiliations(s): 1 IQVIA Brasil, São Paulo-SP, Brazil.
2 Biogen Brasil, São Paulo-SP, Brazil.
3 Proestat Consultoria Estatística, Ribeirão Preto-SP, Brazil. |
Publication(s): PMID: 32119696 PMCID: PMC7051079 DOI: 10.1371/journal.pone.0229768
|
Document Type(s): Article, |
Countries: Brazil, |
Click here for the abstract |
C: Y: |
Oncology, 2020 |
|
L: A: |
English Retrospective database analysis, |
|
|
|
|
Cost of Macrovascular Complications in People With Diabetes From a Public Healthcare Perspective: A Retrospective Database Study in Brazil |
Author(s): Guilherme Silva Julian 1, Daniel Campos 1, Julie Broe Honore 2, Flávia Sauer Tobaruella 3, Jung Hyun Yoon 3, Nino Hallén 2 |
Affiliations(s): 1 IQVIA Brasil, São Paulo, Brazil.
2 Novo Nordisk A/S, Søborg, Denmark.
3 Novo Nordisk Farmacêutica Do Brasil Ltda, São Paulo, Brazil. |
Publication(s): PMID: 32372710 DOI: 10.1080/13696998.2020.1764966
|
Document Type(s): Article, |
Countries: Brazil, |
Click here for the abstract |
C: Y: |
Diabetes, 2020 |
|
L: A: |
English Observational study, Retrospective database analysis, |
|
|
|
|
Clinical characteristics of Glioblastoma Multiforme (GBM) Patients Who Reached 400 Days Post Diagnostic from a Retrospective Real-World Data |
Author(s): Mitrofan L.M.1,Krukas-Hampel M.R.2, Mendoza L.A.3 |
Affiliations(s): 1 IQVIA, Paris, FR; 2IQVIA New York, US; 3IQVIA, Prague, CZ |
Publication(s): ESMO 2018
|
Document Type(s): Poster, |
Countries: Australia, Brazil, Canada, France, Germany, Italy, Mexico, Spain, Taiwan, UK, |
C: Y: |
Oncology, 2018 |
|
L: A: |
English
|
|
|
|
|
Clinical Characteristics of 3,030 Glioblastoma Multiforme (GBM) Patients in High, Upper Middle and Lower Middle Economic Regions Based on Real-World Data (RWD) |
Author(s): Mitrofan L1 , M.R. Krukas-Hampel M.R2 , L.A. Mendoza L.A3 |
Affiliations(s): IQVIA, Paris, FR; IQVIA New York, US; IQVIA, Prague, CZ |
Publication(s): ESMO 2018
|
Document Type(s): Poster, |
Countries: Australia, Brazil, Canada, France, Germany, Italy, Mexico, Spain, Taiwan, UK, |
C: Y: |
Oncology, 2018 |
|
L: A: |
English
|
|
|
|
|
Direct Costs of Type 2 Diabetes from fhe Brazilian Public Healthcare Sector Perspective |
Author(s): Hnoosh A1, Babineaux SM2, Piras de Oliveira C3, McDonell A1, Vega-Hernandez G1 |
Affiliations(s): 1IMS, London, England, 2Eli Lilly & Company, Indianapolis, IN, USA, 3Eli Lilly do Brasil, Sao Paulo, Brazil |
Publication(s): ISPOR 4th Latin America Conference. Value in Health 2013
|
Document Type(s): Poster, |
Countries: Brazil, |
C: Y: |
Diabetes, 2013 |
|
L: A: |
English Burden of illness, Cost analysis, Cost of illness, |
|
|
|
|
Direct Medical Management Costs of Diabetes-Related Complications in Brazil |
Author(s): Vega-Hernández G1; Hnoosh A1; Jugrin A1; Todorova L2; Hansen BB3 |
Affiliations(s): 1 IMS Health, HEOR, London, UK; 2 Novo Nordisk International Operations, Zurich, Switzerland; 3 Novo Nordisk A/S, Soeborg, Denmark |
Publication(s): ISPOR 17th Annual International Meeting, June 2-6 2012, Washington, USA
|
Document Type(s): Abstract, |
Countries: Brazil, |
C: Y: |
Diabetes, 2012 |
|
L: A: |
English Cost analysis, |
|
|
|
|
|
|